Cybrdi, Inc. Stock

CYDI

US23254K1007

Biotechnology & Medical Research

Delayed OTC Markets			5-day change	1st Jan Change
- ^USD	-.--%		-.--%	-50.91%

31/10/17	Xi’an Alena Biotechnology Co., Ltd completed the acquisition of 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc..	CI
19/07/17	Xi’an Alena Biotechnology Co., Ltd entered into a share transfer agreement to acquire 80% stake in Shaanxi Chaoying Bio-Technology Co., Ltd. from Cybrdi, Inc. for CNY 25.6 million.	CI

Cybrdi Inc is a united states-based company, which operates as a holding company. The Company's subsidiaries include Chaoying Biotech which is engaged in biotechnology manufacturing, and research and development company. Through Chaoying Biotech, Cybrdi controls SD Chaoying, a Cultural and Entertainment company. Its key product is tissue chips, intended to provide high-throughput molecular profiling and parallel analysis of biological and molecular characteristics for hundreds of pathologically controlled tissue specimens. The Companyâ€™s Tissue Microarrays (TMAs) segment offers a variety of tissue array products and services on the commercial market. The Technical Services segment provides in-house technical services platform to perform customized research according to customer specifications. The Culture, Entertainment, and Real Estate Business segment is developing a Culture and Entertainment Square in Changle City of Shandong Province.

Employees

Sector

Biotechnology & Medical Research

More about the company

Stock Market
Stocks
CYDI Stock

The best tools reserved for subscribers to boost the performance of your investments!

Market Cap	2.52M 2.27M 2.12M 1.92M 3.6M 240M 3.63M 25.42M 9.93M 125M 9.48M 9.27M 401M	P/E 2012	-1.82x	P/E 2013	-2.85x
Enterprise Value	6.51M 5.86M 5.47M 4.95M 9.3M 620M 9.36M 65.6M 25.61M 322M 24.46M 23.93M 1.03B	EV / Sales 2012	3.25x	EV / Sales 2013	9.67x
Free-Float	29.19%	Yield 2012 *	-	Yield 2013	-

Manager	Title	Age	Since
Yan Biao Bai CEO	Chief Executive Officer	63	01/01/2003
Yong Hong Ren COO	Chief Operating Officer	-	19/08/2011

Director	Title	Age	Since
Yan Biao Bai CHM	Chairman	63	01/01/2003
Yong Hong Ren BRD	Director/Board Member	-	19/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CYBRDI, INC.	-.--%	-.--%	-	-	325K
WUXI APPTEC CO., LTD.	-2.01%	-7.86%	+60.74%	+70.97%	70.44B
ARGENX SE	+3.84%	-11.02%	+8.59%	+57.43%	50.31B
LONZA GROUP AG	+3.35%	+1.42%	+11.85%	+40.01%	47.51B
IQVIA HOLDINGS INC.	+0.51%	+1.51%	+27.96%	+31.43%	42.91B
REVOLUTION MEDICINES, INC.	+2.70%	-3.66%	+307.41%	+547.01%	40.39B
BEONE MEDICINES AG	+0.69%	-3.44%	+9.52%	+96.59%	39.69B
CELLTRION, INC.	+0.06%	-2.02%	+11.25%	+43.27%	30.59B
WUXI BIOLOGICS (CAYMAN) INC.	-2.95%	-12.28%	+43.51%	+1.30%	26.8B
BIONTECH SE	-0.39%	-6.92%	-13.60%	-14.40%	22.36B
Average	+0.58%	-4.60%	+51.91%	+97.07%	37.1B
Weighted average by Cap.	+0.76%	-4.90%	+55.18%	+102.70%

	2012	2013
Net sales	783K 704K 657K 596K 1.12M 74.53M 1.13M 7.89M 3.08M 38.68M 2.94M 2.88M 124M	574K 516K 482K 437K 820K 54.65M 825K 5.78M 2.26M 28.36M 2.16M 2.11M 91.22M
Net income	-530K -476K -445K -403K -756K -50.42M -761K -5.33M -2.08M -26.17M -1.99M -1.95M -84.16M	-548K -493K -460K -417K -783K -52.18M -788K -5.52M -2.16M -27.08M -2.06M -2.01M -87.11M
Net Debt	1.58M 1.42M 1.33M 1.2M 2.26M 151M 2.27M 15.94M 6.22M 78.19M 5.94M 5.82M 251M	3.99M 3.59M 3.35M 3.03M 5.7M 380M 5.73M 40.18M 15.69M 197M 14.98M 14.66M 634M

Cybrdi, Inc. Stock

Stocks

CYDI

US23254K1007

Biotechnology & Medical Research

Valuation: Cybrdi, Inc.

Latest news: Cybrdi, Inc.

Managers and Directors: Cybrdi, Inc.

Other Biotechnology & Medical Research

Financials

Company Profile